NHI: National Health Investors, Inc. Stock

by  •  • Comments Off on NHI: National Health Investors, Inc. Stock

SIC 6798 – Real Estate Investment Trusts

Valuation
Market Cap ($M) 3,503.86
Enterprise Value ($M) 4,643.07
Book Value ($M) 1,247.41
Book Value / Share 27.46
Price / Book 2.81
NCAV ($M) -1,090.47
NCAV / Share -24.01
Price / NCAV -3.21

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.10

Liquidity (mrq)
Quick Ratio 1.69
Current Ratio 1.69

Balance Sheet (mrq) ($M)
Current Assets 122.22
Assets 2,460.09
Liabilities 1,212.68
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 14.16 -2.15
01-08 13G/A BlackRock, Inc. 10.00 2.58

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PU
2024-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT P
2024-02-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRAN
2024-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 17,328 121,547 14.26
2024-11-21 24,355 138,427 17.59
2024-11-20 10,244 96,538 10.61
2024-11-19 9,613 84,977 11.31
2024-11-18 7,572 83,887 9.03

(click for more detail)

Similar Companies
MPW – Medical Properties Trust, Inc. MSB – Mesabi Trust
MTR – Mesa Royalty Trust NLOP – Net Lease Office Properties
NLY – Annaly Capital Management, Inc.


Financial data and stock pages provided by
Fintel.io